Charles S. Berkman - 15 Feb 2025 Form 4 Insider Report for OmniAb, Inc. (OABI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Feb 2025, 20:50:51 UTC
Prior SEC filing
22 Jan 2025
Next SEC filing
07 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Charles S. Berkman

Key filing fact

Charles S. Berkman filed Form 4 for OmniAb, Inc. (OABI) on 19 Feb 2025.

Key facts

  • This page summarizes Charles S. Berkman's Form 4 filing for OmniAb, Inc. (OABI).
  • 8 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 19 Feb 2025, 20:50.

Change

  • Previous filing in this sequence was filed on 22 Jan 2025.
  • Current net transaction value: -$56,857.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OABI transaction

Common Stock

Options Exercise

Transaction value
Shares
+15,615
Change %
+4.5%
Price
Shares after
358,805
Date
15 Feb 2025
Ownership
Direct
Footnotes
F1, F2
OABI transaction

Common Stock

Options Exercise

Transaction value
Shares
+13,541
Change %
+3.8%
Price
Shares after
372,346
Date
16 Feb 2025
Ownership
Direct
Footnotes
F2, F3
OABI transaction

Common Stock

Sale

Transaction value
$30,231
Shares
-8,215
Change %
-2.2%
Price
$3.68
Shares after
364,131
Date
18 Feb 2025
Ownership
Direct
Footnotes
F4, F5
OABI transaction

Common Stock

Sale

Transaction value
$26,626
Shares
-7,255
Change %
-2%
Price
$3.67
Shares after
356,876
Date
19 Feb 2025
Ownership
Direct
Footnotes
F4, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OABI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-15,615
Change %
-16%
Price
$0.000000
Shares after
83,330
Date
15 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,615
Exercise price
$0.000000
Footnotes
F1, F2
OABI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-13,541
Change %
-16%
Price
$0.000000
Shares after
69,789
Date
16 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
13,541
Exercise price
$0.000000
Footnotes
F2, F3
OABI transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+56,250
Change %
+81%
Price
$0.000000
Shares after
126,039
Date
18 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
56,250
Exercise price
$0.000000
Footnotes
F2, F7
OABI transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+337,500
Change %
Price
$0.000000
Shares after
337,500
Date
18 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
337,500
Exercise price
$3.66
Footnotes
F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Represents the vesting of an RSU grant which occurs in three substantially equal annual installments beginning on February 15, 2023.

Footnote F2

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F3

Represents the vesting of an RSU grant which occurs in three substantially equal annual installments beginning on February 16, 2025

Footnote F4

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and do not represent discretionary trades by the reporting person.

Footnote F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.83. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.71. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F7

The RSU grant vests in three substantially equal annual installments beginning on February 18, 2026.

Footnote F8

The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .